Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Pharmaceutical intermediates>Heterocyclic compound>Pyridine compound>Pyridine derivatives>1,8-Diazabicyclo[5.4.0]Undec-7-Ene
1,8-Diazabicyclo[5.4.0]Undec-7-Ene
  • 1,8-Diazabicyclo[5.4.0]Undec-7-Ene
  • 1,8-Diazabicyclo[5.4.0]Undec-7-Ene
  • 1,8-Diazabicyclo[5.4.0]Undec-7-Ene

1,8-Diazabicyclo[5.4.0]Undec-7-Ene

Price $7780
Package 10G
Min. Order: 10G
Supply Ability: 500KG
Update Time: 2022-05-20

Product Details

Product Name: 1,8-Diazabicyclo[5.4.0]Undec-7-Ene CAS No.: 6674-22-2
Min. Order: 10G Purity: API Standards
Supply Ability: 500KG Release date: 2022/05/20

1,8-Diazabicyclo[5.4.0]undec-7-ene(DBU) is a bicyclic amidine base. It is non-nucleophilic, sterically hindered, tertiary amine base in organic chemistry. 


Primary Usage :

Used for analytical purpose only


Application :

1,8-Diazabicyclo[5.4.0]undec-7-ene, is used in organic synthesis as a catalyst, a complexing ligand, and a non-nucleophilic base. It is also used in a new synthesis of the ABCD ring system of Camptothecin .

Company Profile Introduction

You may like

Recommended supplier

Product name Price   Suppliers Update time
$5.00/1KG
VIP4Y
Hebei Chuanghai Biotechnology Co,.LTD
2024-08-21
$40.00/1kg
VIP1Y
Hebei Zhuanglai Chemical Trading Co.,Ltd
2024-05-08
$0.00/10mg
VIP1Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2024-04-09
$0.00/1Kg
VIP1Y
airuikechemical co., ltd.
2024-04-08
$20.00/10kg
VIP1Y
Shandong Juchuang Chemical Co., LTD
2024-03-11
$50.00/1KG
VIP1Y
Henan Fengda Chemical Co., Ltd
2023-12-22
$80.00/1kg
VIP2Y
Zibo Hangyu Biotechnology Development Co., Ltd
2023-11-01
$0.00/1kg
VIP2Y
Hebei Kingfiner Technology Development Co.Ltd
2023-06-06
$0.00/25KG
VIP4Y
WUHAN FORTUNA CHEMICAL CO., LTD
2023-01-31
$0.00/1kg
VIP3Y
Henan Aochuang Chemical Co.,Ltd.
2022-09-16

CLEARSYNTH LABS LTD.

3YR United StatesUnited States
INQUIRY